Maya M. Davis, Ph.D.

Quality & Compliance Practice

BACKGROUND

FOCUS AREAS

AWARDS & HONORS

16 years with the FDA focused in the pharmaceutical sector.

Compliance strategies, inspection readiness, remote regulatory assessments, pharmaceutical quality systems.

– Potential Supervisors Program Cohort 5 in 2022
– FDA Commissioner’s – Special Citation in 2013
– CDER Team Excellence Awards in 2024, 2017
– FDA Honor Awards in 2020, 2019, 2015
– FDA Group Recognition Awards in 2014, 2012

As Senior Vice President of Regulatory Compliance at ELIQUENT Life Sciences, Maya Davis offers strategic guidance to clients to help gain and maintain market authorization.

Maya Davis brings 16 years of regulatory experience to her role as Senior Vice President, Regulatory Compliance at Eliquent Life Sciences.

Maya brings a holistic understanding of FDA’s regulatory framework. Starting in the New England District, Maya brings 6 years of experience in Investigations, 4 years in Compliance, 3 years in Mutual Recognition Agreements (MRA), and 3 years in CDER Surveillance, She also brings leadership experience with details as Acting Director of Compliance Branch, Acting Branch Chief for foreign drug inspections, and Acting Supervisory Investigator for the BIMO team. Other career highlights also include referring precedent setting cases under MRA, serving on the Massachusetts Board of Registration in Pharmacy Advisory Committee as an Aseptic Processing Expert, and work in Quality Management Maturity and remote regulatory assessments.

At Eliquent, Maya offers strategic guidance to the pharmaceutical, medical device, and dietary supplement industries. This includes compliance strategies, corrective and preventive action plans, inspection readiness, audits, mock inspections, due diligence, training, coaching, and mentoring.

Maya received a B.A. in Neuroscience from Amherst College, and an M.S., M.Ph., and Ph.D. from Yale University in Pharmacology.

Contact us today and learn how ELIQUENT guides companies from risk to readiness.